From: Implication of plasma gelsolin in systemic lupus erythematosus patients
Parameter | SLE patients (n = 50) | |||||||
---|---|---|---|---|---|---|---|---|
Sens. (%) | Spec. (%) | PPV (%) | NPV (%) | Acc. (%) | AUC | 95%CI | p | |
Plasma gelsolin ≤ 78.95 mg/l | 100 | 71.9 | 66.7 | 100 | 82 | 0.95 | 0.897–1 | < 0.001 |
Anti-ds DNA ≥ 54 IU/ml | 88.9 | 59.4 | 55.2 | 90.5 | 70 | 0.75 | 0.61–0.88 | 0.004 |